119 related articles for article (PubMed ID: 36066170)
1. Study on the effects of ranibizumab as a pretreatment for vitrectomy in proliferative diabetic retinopathy: a retrospective cohort study.
Zhou HW; Chen K
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5939-5945. PubMed ID: 36066170
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy.
Chen HJ; Wang CG; Dou HL; Feng XF; Xu YM; Ma ZZ
Ann Palliat Med; 2020 Jan; 9(1):82-89. PubMed ID: 32005066
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy.
Hu L; Chen Q; Du Z; Wang W; Zhao G
Int Ophthalmol; 2021 May; 41(5):1635-1642. PubMed ID: 33538931
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.
Li S; Yang Y; Zou J; Zeng J; Ding C
BMC Ophthalmol; 2022 Feb; 22(1):63. PubMed ID: 35139812
[TBL] [Abstract][Full Text] [Related]
5. Conbercept and Ranibizumab Pretreatments in Vitrectomy with Silicone Oil Infusion for Severe Diabetic Retinopathy.
Yang KB; Zhang H; Li SJ; Cao JJ; Cheng LN; Lin YX; Tian ZC; Li J; Gu F; Liu ZL
J Ocul Pharmacol Ther; 2019 Apr; 35(3):161-167. PubMed ID: 30668279
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review and Meta-Analysis of Clinical Outcomes of Small Gauge Vitrectomy with or without Intravitreal Anti-Vascular Endothelial Growth Factor Agents Pretreatment for Proliferative Diabetic Retinopathy.
Pei M; Zhao X; Wan G
Ophthalmic Res; 2023; 66(1):777-790. PubMed ID: 36972566
[TBL] [Abstract][Full Text] [Related]
7. Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy.
Guan J; Cai N; Liu LM; Zhao N; Liu NN
Diabetes Ther; 2020 Jun; 11(6):1397-1406. PubMed ID: 32356244
[TBL] [Abstract][Full Text] [Related]
8. The impact of ranibizumab on the level of intercellular adhesion molecule type 1 in the vitreous of eyes with proliferative diabetic retinopathy.
Yan Y; Zhu L; Hong L; Deng J; Song Y; Chen X
Acta Ophthalmol; 2016 Jun; 94(4):358-64. PubMed ID: 26285163
[TBL] [Abstract][Full Text] [Related]
9. Proliferative diabetic retinopathy treated with intravitreal ranibizumab and photocoagulation directed at ischemic retinal areas-A randomized study.
Toscano L; Messias A; Messias K; de Cenço Lopes R; Ribeiro JAS; Scott IU; Jorge R
Doc Ophthalmol; 2021 Dec; 143(3):313-322. PubMed ID: 34347216
[TBL] [Abstract][Full Text] [Related]
10. Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients.
Li S; Tang J; Han X; Wang Z; Zhang L; Zhao M; Qu J
Ophthalmol Ther; 2022 Oct; 11(5):1833-1845. PubMed ID: 35904708
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
Gao S; Lin Z; Chen Y; Xu J; Zhang Q; Chen J; Shen X
J Ocul Pharmacol Ther; 2020 Jun; 36(5):304-310. PubMed ID: 32186940
[No Abstract] [Full Text] [Related]
12. Efficacy comparison of intravitreal injections of conbercept and ranibizumab for severe proliferative diabetic retinopathy.
Lu Q; Lu L; Chen B; Chen W; Lu P
Can J Ophthalmol; 2019 Jun; 54(3):291-296. PubMed ID: 31109466
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal Ranibizumab Alone or in Combination with Calcium Dobesilate for the Treatment of Diabetic Macular Edema in Nonproliferative Diabetic Retinopathy Patients: 12-Month Outcomes of a Retrospective Study.
Wang D; Wang H; Wu S; Yang X; Xu J
Int J Clin Pract; 2022; 2022():6725225. PubMed ID: 36340967
[TBL] [Abstract][Full Text] [Related]
14. Ranibizumab pretreatment in diabetic vitrectomy: a pilot randomised controlled trial (the RaDiVit study).
Comyn O; Wickham L; Charteris DG; Sullivan PM; Ezra E; Gregor Z; Aylward GW; da Cruz L; Fabinyi D; Peto T; Restori M; Xing W; Bunce C; Hykin PG; Bainbridge JW
Eye (Lond); 2017 Sep; 31(9):1253-1258. PubMed ID: 28498374
[TBL] [Abstract][Full Text] [Related]
15. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.
Diabetic Retinopathy Clinical Research Network*
JAMA Ophthalmol; 2013 Mar; 131(3):283-93. PubMed ID: 23370902
[TBL] [Abstract][Full Text] [Related]
16. Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.
Zhao XY; Xia S; Chen YX
Br J Ophthalmol; 2018 Aug; 102(8):1077-1085. PubMed ID: 29246890
[TBL] [Abstract][Full Text] [Related]
17. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
[TBL] [Abstract][Full Text] [Related]
18. Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy.
Xu J; Zhao M; Li JP; Liu NP
BMC Ophthalmol; 2020 Apr; 20(1):149. PubMed ID: 32295566
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal ranibizumab alone or in combination with panretinal photocoagulation for the treatment of proliferative diabetic retinopathy with coexistent macular edema: long-term outcomes of a prospective study.
Chatziralli I; Dimitriou E; Theodossiadis G; Kazantzis D; Theodossiadis P
Acta Diabetol; 2020 Oct; 57(10):1219-1225. PubMed ID: 32472172
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.
Chatziralli I; Dimitriou E; Theodossiadis G; Bourouki E; Bagli E; Kitsos G; Theodossiadis P
Int Ophthalmol; 2020 Apr; 40(4):841-847. PubMed ID: 31788713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
